Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.3M
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
30.2M
-
Shares change
-
-2.89M
-
Total reported value, excl. options
-
$437M
-
Value change
-
-$34.4M
-
Put/Call ratio
-
0.39
-
Number of buys
-
73
-
Number of sells
-
-58
-
Price
-
$14.58
Significant Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) as of Q3 2025
202 filings reported holding DNA - Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share as of Q3 2025.
Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.2M shares
of 48.3M outstanding shares and own 62.49% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (3.58M shares), BlackRock, Inc. (3.42M shares), BAILLIE GIFFORD & CO (3.24M shares), VANGUARD GROUP INC (2.48M shares), Erste Asset Management GmbH (2.2M shares), Anchorage Capital Group, L.L.C. (1.75M shares), Legal & General Group Plc (1.61M shares), BANK OF AMERICA CORP /DE/ (1.07M shares), FORBES J M & CO LLP (1.06M shares), and STATE STREET CORP (934K shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.